drugset
drugset / Trial / NCT00760747

Comparison of Slow and Fast Transition From Stimulants to Atomoxetine in Children and Adolescents With Attention Deficit/Hyperactivity Disorder(ADHD)

NCT00760747 ↗

Phase 4 Completed 112 enrolled Eli Lilly and Company
RandomizedParallel-groupOpen-labelTreatment

Summary

Children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) who are not tolerating or not responding well to stimulant therapy will be included in this study. Two different strategies for transition from Stimulant to Atomoxetine will be used: Slow (10 weeks) and fast (2 weeks). Changes in ADHD symptoms and tolerability of medication will be compared between the two different switching approaches.

Timeline

Start
2008-09
Primary completion
2010-08
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Atomoxetine Other / unclassified 1.2 mg/kg Oral
Subject Atomoxetine Other / unclassified 1.8 mg/kg Oral

Indications

attention deficit-hyperactivity disorder